MediWound (MDWD)
Clears burn eschar and chronic wounds with enzymatic technology instead of surgery.
$13.53
vs last close−0.42 (−3.02%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 45.54% | 5.84M ADS | |
|---|---|---|---|
| 83 holders · as of Jun 30, 2026 | |||
| Insiders | 9.19% | 1.18M ADS | |
| 11 holders · as of Sep 2, 2026 | |||
| Other | 45.27% | 5.81M ADS | |
| remainder | |||
12.84M ADS as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
83 holders · 5.84M shares · 17 new positions · 46 increased · 19 reduced · 13 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Investor AB | 872.1K | 6.79% | 0 | Aug 14, 2026 |
| Yelin Lapidot Holdings Management Ltd. | 758.2K | 5.91% | −4.6K | Aug 3, 2026 |
| Rosalind Advisors, Inc. | 749.1K | 5.84% | 0 | Aug 14, 2026 |
| Price T Rowe Associates Inc /MD/ | 641.1K | 4.99% | −68.8K | Aug 14, 2026 |
| BlackRock, Inc. | 525.9K | 4.10% | +80.1K | Aug 7, 2026 |
| Sphera Funds Management Ltd. | 273.2K | 2.13% | 0 | Aug 14, 2026 |
| Silverberg Bernstein Capital Management LLC | 228.1K | 1.78% | +28.1K | Jul 7, 2026 |
| State Street Corp | 168.7K | 1.31% | +24.9K | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Access Industries Holdings LLCincl. Clal Life Sciences L.P., Access Industries, LLC +4 more | 11.56% | 1.48M | 13D | Oct 3, 2025 |
| HOLD Alapkezelo Zrt. | 8.10% | 1.04M | 13G | Feb 13, 2026 |
| Rosalind Advisors, Inc. | 7.00% | 912.3K | 13G | Feb 11, 2026 |
| Yelin Lapidot Holdings Management Ltd. | 5.95% | 763.1K | 13G | Feb 5, 2026 |
| T. Rowe Price Associates, Inc. | 5.50% | 709.8K | 13G | May 15, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 1, 2026 | Samuel Rubinsteindirector | Purchase | 525 | $12.62 | 525 |
| Sep 1, 2026 | Samuel Rubinsteindirector | Sale | 525 | $12.72 | 0 |
| Aug 27, 2026 | Shmuel Hessofficer: COO & Chief Commercial Officer | Sale · 2 lots | 3,958 | $12.92 | 0 |
| Aug 26, 2026 | Shmuel Hessofficer: COO & Chief Commercial Officer | Sale | 1,865 | $13.00 | 0 |
| Jun 3, 2026 | Nachum Shamirdirector | Purchase · 2 lots | 6,000 | $14.00 | 55,815 |
| Jun 1, 2026 | David Morton Foxdirector | Purchase · 3 lots | 3,537 | $14.11 | 22,283 |
| May 29, 2026 | Samuel Rubinsteindirector | Purchase | 150 | $14.33 | 2,993 |
House and Senate disclosures
Not reported.